INTEGRATION OF CLINICAL, MOLECULAR, AND IMMUNE FEATURES TO IMPROVE RISK STRATIFICATION AND OUTCOMES IN MELANOMA PATIENTS WITH SENTINEL LYMPH NODE MET

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators